ATMP – Business Models and Health Economy

The final report of the Swelife-ATMP Business Models and Health Economy project is now available. IHE with Ulf Persson has been one of the involved partners.

The report investigates health economic questions such as valuation and payment for ATMPs. The report is in Swedish but several of the Appendix documents are in English.

The report and supplementing information can be found here

Advanced Therapy Medicinal Products (ATMPs) are ‘Biologics’ medicines for human use with an active therapeutic substance produced through biological processes. ATMP is an EU specific classification, ensuring that these products are regulated as medicines.